Tandem Diabetes Care, Inc. (TNDM)
NASDAQ: TNDM · Real-Time Price · USD
14.34
-0.96 (-6.27%)
At close: Jun 22, 2026, 4:00 PM EDT
14.26
-0.08 (-0.56%)
Pre-market: Jun 23, 2026, 7:00 AM EDT
Tandem Diabetes Care Employees
Tandem Diabetes Care had 2,500 employees as of December 31, 2025. The number of employees decreased by 150 or -5.66% compared to the previous year.
Employees
2,500
Change (1Y)
-150
Growth (1Y)
-5.66%
Revenue / Employee
$411,014
Profits / Employee
-$37,819
Market Cap
982.71M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 2,500 | -150 | -5.66% |
| Dec 31, 2024 | 2,650 | 250 | 10.42% |
| Dec 31, 2023 | 2,400 | -200 | -7.69% |
| Dec 31, 2022 | 2,600 | 600 | 30.00% |
| Dec 31, 2021 | 2,000 | 500 | 33.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AdaptHealth | 10,900 |
| Enovis | 7,802 |
| QuidelOrtho | 6,500 |
| CONMED | 3,900 |
| Avanos Medical | 2,287 |
| Artivion | 1,800 |
| Inspire Medical Systems | 1,333 |
| PROCEPT BioRobotics | 888 |
TNDM News
- 14 days ago - Tandem Diabetes Care Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 17 days ago - Tandem Diabetes receives CE Mark for expanded indications of AID systems - TheFly
- 17 days ago - Tandem Diabetes Care Automated Insulin Delivery Systems Receive CE Mark for Type 2 Diabetes and Type 1 Diabetes During Pregnancy - Business Wire
- 22 days ago - Wells upgrades Tandem Diabetes on ‘transformational’ pharmacy model - TheFly
- 22 days ago - Tandem Diabetes upgraded to Overweight from Equal Weight at Wells Fargo - TheFly
- 25 days ago - Tandem Diabetes price target lowered to $17 from $22 at Citi - TheFly
- 26 days ago - Tandem Diabetes price target lowered to $21 from $24 at Goldman Sachs - TheFly
- 4 weeks ago - Tandem Diabetes Care Transcript: AGM 2026 - Transcripts